2024-04-19 09:49:09
(ANSA) – ROME, APRIL 19 – For every patient today it is possible to have an increasingly detailed and precise ‘photograph’ of the tumor that has affected him, with the possibility of personalized treatments. In fact, in Italy there are over 31 thousand cases per year of neoplasms with gene mutations, i.e. tumors that present particular gene mutations, and this opens the doors to precision medicine which makes treatments more targeted. The priority is therefore to implement the personalization of diagnostic-therapeutic tools and it is also necessary to reorganize clinical trials through AI. This is the message of the experts on the occasion of the 4th international conference Italian Summit On Precision Medicine, which brings together in Rome over 150 oncologists from all over Europe and the United States to discuss the future prospects of precision oncology Over 31 thousand new cases of cancer per year are therefore linked to alterations of genes involved in the onset and development of neoplasms. The most frequent are: breast cancer (5,500), colorectal cancer (2,800), lung cancer (2,200), prostate cancer (2,100) and pancreatic cancer (2,045). Precision medicine “is a surprising innovation and must change our approach to over 200 oncological diseases – states Paolo Marchetti, president of the Foundation for Personalized Medicine – Fmp -.
The identification of pathogenetic variants of some genes is important in all phases of oncological disease, from diagnosis to metastatic phases, without forgetting that some of these alterations can guide more effective prevention paths by concentrating often high-cost investigations in people at risk of developing onset of disease due to the presence of specific genomic alterations. It is thus possible to achieve effective prevention with early therapeutic interventions.”
(ANSA).
2024-04-19 09:49:09